Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ACADIA Pharmaceuticals (GB:0A4W)
LSE:0A4W
RESEARCH TOOLSreports
Holding GB:0A4W?
Track your performance easily
See the Price Targets and Ratings of:
0A4W Analyst Ratings
Moderate Buy
13 Buy
6 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0A4W Stock 12 Month Forecast
Average Price Target
$25.59
▲(76.75% Upside)
| Highest Price Target$39.00 | Average Price Target$25.59 | Lowest Price Target$12.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Raymond James
Initiated
10/10/24
RBC Capital
Reiterated
10/04/24
BMO Capital
Reiterated
09/27/24
Morgan Stanley
Reiterated
09/23/24
Oppenheimer
Reiterated
08/09/24
Goldman Sachs
Reiterated
08/08/24
Bank of America Securities
Reiterated
08/08/24
Citi
Reiterated
08/08/24
Cantor Fitzgerald
Reiterated
08/07/24
TD Cowen
Assigned
08/07/24
Canaccord Genuity
$33
Buy
127.93%
Upside
Reiterated
08/07/24
ACADIA Pharmaceuticals Buy Rating Affirmed: Strong Nuplazid Sales and Promising Growth Trajectory
J.P. Morgan
―
Buy
―
Reiterated
08/07/24
Buy Rating Justified by ACADIA Pharmaceuticals' Solid Performance and Promising Market Expansion
H.C. Wainwright
$27
Buy
86.49%
Upside
Reiterated
08/07/24
ACADIA Pharmaceuticals: Strong Buy Rating on Growth Prospects and Side Effect Management
Guggenheim
$26→$23
Buy
58.86%
Upside
Reiterated
08/07/24
Acadia Pharmaceuticals price target lowered to $23 from $26 at GuggenheimAcadia Pharmaceuticals price target lowered to $23 from $26 at Guggenheim
Best Analysts Covering ACADIA Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy GB:0A4W and Sell After:
1 Month
xxx
Success Rate
17/34 ratings generated profit
Average Return
+0.59%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +0.59% per trade.
3 Months
xxx
Success Rate
15/24 ratings generated profit
Average Return
+6.08%
assigned a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +6.08% per trade.
1 Year
Success Rate
13/24 ratings generated profit
Average Return
+5.16%
assigned a buy rating 2 months ago
Copying Ritu Baral's trades and holding each position for 1 Year would result in 54.17% of your transactions generating a profit, with an average return of +5.16% per trade.
2 Years
xxx
Success Rate
11/34 ratings generated profit
Average Return
+6.39%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 32.35% of your transactions generating a profit, with an average return of +6.39% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0A4W Analyst Recommendation Trends
Rating
Jun 24
Jul 24
Aug 24
Sep 24
Oct 24
Strong Buy
13
13
13
12
10
Buy
0
0
5
5
5
Hold
5
6
7
8
7
Sell
0
0
1
1
1
Strong Sell
0
0
0
0
0
total
18
19
26
26
23
Each month's total comprises the sum of three months' worth of ratings.
0A4W Financial Forecast
0A4W Stock Forecast FAQ
What is GB:0A4W’s average 12-month price target, according to analysts?
Based on analyst ratings, ACADIA Pharmaceuticals’s 12-month average price target is $25.59.
What is GB:0A4W’s upside potential, based on the analysts’ average price target?
ACADIA Pharmaceuticals has 76.75% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ACADIA Pharmaceuticals a Buy, Sell or Hold?
ACADIA Pharmaceuticals has a consensus rating of Moderate Buy, which is based on 13 buy ratings, 6 hold ratings and 1 sell ratings.
What is ACADIA Pharmaceuticals’s share price target?
The average share price target for ACADIA Pharmaceuticals is $25.59. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $39.00 ,and the lowest forecast is $12.00. The average share price target represents 76.75% Increase from the current price of $14.478.
The highest analyst share price target is $39.00 ,and the lowest forecast is $12.00. The average share price target represents 76.75% Increase from the current price of $14.478.
What do analysts say about ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 20 Wall Streets Analysts.
How can I buy shares of ACADIA Pharmaceuticals?
To buy shares of GB:0A4W, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.